HEADER OXIDOREDUCTASE 06-AUG-08 3E39 TITLE CRYSTAL STRUCTURE OF A PUTATIVE NITROREDUCTASE IN COMPLEX WITH FMN TITLE 2 (DDE_0787) FROM DESULFOVIBRIO DESULFURICANS SUBSP. AT 1.70 A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE NITROREDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DESULFOVIBRIO DESULFURICANS SUBSP. SOURCE 3 DESULFURICANS STR. G20; SOURCE 4 ORGANISM_TAXID: 207559; SOURCE 5 GENE: YP_387283.1, DDE_0787; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 24-JUL-19 3E39 1 REMARK LINK REVDAT 4 25-OCT-17 3E39 1 REMARK REVDAT 3 23-MAR-11 3E39 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 3E39 1 VERSN REVDAT 1 19-AUG-08 3E39 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE NITROREDUCTASE IN COMPLEX WITH JRNL TITL 2 FMN (YP_387283.1) FROM DESULFOVIBRIO DESULFURICANS G20 AT JRNL TITL 3 1.70 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.09 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 36077 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1806 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2485 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.2180 REMARK 3 BIN FREE R VALUE SET COUNT : 134 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2664 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 373 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.59000 REMARK 3 B22 (A**2) : 0.34000 REMARK 3 B33 (A**2) : -0.94000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.110 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.106 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.071 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.118 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2854 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1911 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3903 ; 1.524 ; 1.998 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4652 ; 0.983 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 363 ; 4.117 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 130 ;30.633 ;23.231 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 452 ;10.441 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;10.254 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 442 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3187 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 557 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 581 ; 0.221 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2253 ; 0.216 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1370 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1413 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 249 ; 0.157 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.127 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 55 ; 0.284 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 28 ; 0.171 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1913 ; 1.856 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 698 ; 0.478 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2836 ; 2.440 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1225 ; 3.766 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1058 ; 5.229 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 5 A 174 6 REMARK 3 1 B 5 B 174 6 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 LOOSE POSITIONAL 1 A (A): 2162 ; 0.340 ; 5.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 2162 ; 1.870 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION REMARK 3 3. ACETATE AND PGE (PEG400 FRAGMENTS) WERE MODELED BASED REMARK 3 ON CRYSTALLIZATION CONDITIONS. REMARK 3 4. COFACTOR FMN WAS FOUND BOUND TO THE PROTEIN. REMARK 4 REMARK 4 3E39 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-AUG-08. REMARK 100 THE DEPOSITION ID IS D_1000048819. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918370,0.979421,0.979155 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(311) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : VERTICAL FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36111 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 28.094 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.8500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.46100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40.0000% PEG-400, 0.1M ACETATE PH 4.5, REMARK 280 VAPOR DIFFUSION,SITTING DROP,NANODROP, TEMPERATURE 277K, VAPOR REMARK 280 DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.89000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.87000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.99500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.87000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.89000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.99500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE PROTOMER MAY FORM A DIMER BASED ON REMARK 300 CRYSTAL PACKING ANALYSIS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 LEU A 2 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 LEU B 2 REMARK 465 GLN B 175 REMARK 465 PRO B 176 REMARK 465 GLU B 177 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 4 CG CD OE1 OE2 REMARK 470 ARG A 19 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 70 47.86 -101.49 REMARK 500 ASN A 92 118.93 -164.02 REMARK 500 TYR B 70 41.13 -96.33 REMARK 500 ASN B 92 119.32 -161.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 178 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 178 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 179 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390745 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3E39 A 1 177 UNP Q314Q8 Q314Q8_DESDG 1 177 DBREF 3E39 B 1 177 UNP Q314Q8 Q314Q8_DESDG 1 177 SEQADV 3E39 GLY A 0 UNP Q314Q8 LEADER SEQUENCE SEQADV 3E39 GLY B 0 UNP Q314Q8 LEADER SEQUENCE SEQRES 1 A 178 GLY MSE LEU THR GLU ASN PRO VAL LEU GLN ALA ILE ARG SEQRES 2 A 178 GLN ARG ARG SER ILE ARG ARG TYR THR ASP GLU ALA VAL SEQRES 3 A 178 SER ASP GLU ALA VAL ARG LEU ILE LEU GLU ALA GLY ILE SEQRES 4 A 178 TRP ALA PRO SER GLY LEU ASN ASN GLN PRO CYS ARG PHE SEQRES 5 A 178 LEU VAL ILE ARG ALA ASP ASP PRO ARG CYS ASP ILE LEU SEQRES 6 A 178 ALA ALA HIS THR ARG TYR GLY HIS ILE VAL ARG GLY ALA SEQRES 7 A 178 LYS VAL ILE ILE LEU VAL PHE LEU ASP ARG GLU ALA MSE SEQRES 8 A 178 TYR ASN GLU VAL LYS ASP HIS GLN ALA ALA GLY ALA ALA SEQRES 9 A 178 VAL GLN ASN MSE LEU LEU ALA ALA HIS ALA LEU GLN LEU SEQRES 10 A 178 GLY ALA VAL TRP LEU GLY GLU ILE ILE ASN GLN ALA ALA SEQRES 11 A 178 THR LEU LEU PRO ALA LEU ALA LEU ASP PRO ALA ARG LEU SEQRES 12 A 178 SER PHE GLU ALA ALA ILE ALA ALA GLY HIS PRO ALA GLN SEQRES 13 A 178 ASN GLY SER SER SER ARG ARG PRO LEU ALA GLU LEU LEU SEQRES 14 A 178 LEU GLU GLU PRO PHE PRO GLN PRO GLU SEQRES 1 B 178 GLY MSE LEU THR GLU ASN PRO VAL LEU GLN ALA ILE ARG SEQRES 2 B 178 GLN ARG ARG SER ILE ARG ARG TYR THR ASP GLU ALA VAL SEQRES 3 B 178 SER ASP GLU ALA VAL ARG LEU ILE LEU GLU ALA GLY ILE SEQRES 4 B 178 TRP ALA PRO SER GLY LEU ASN ASN GLN PRO CYS ARG PHE SEQRES 5 B 178 LEU VAL ILE ARG ALA ASP ASP PRO ARG CYS ASP ILE LEU SEQRES 6 B 178 ALA ALA HIS THR ARG TYR GLY HIS ILE VAL ARG GLY ALA SEQRES 7 B 178 LYS VAL ILE ILE LEU VAL PHE LEU ASP ARG GLU ALA MSE SEQRES 8 B 178 TYR ASN GLU VAL LYS ASP HIS GLN ALA ALA GLY ALA ALA SEQRES 9 B 178 VAL GLN ASN MSE LEU LEU ALA ALA HIS ALA LEU GLN LEU SEQRES 10 B 178 GLY ALA VAL TRP LEU GLY GLU ILE ILE ASN GLN ALA ALA SEQRES 11 B 178 THR LEU LEU PRO ALA LEU ALA LEU ASP PRO ALA ARG LEU SEQRES 12 B 178 SER PHE GLU ALA ALA ILE ALA ALA GLY HIS PRO ALA GLN SEQRES 13 B 178 ASN GLY SER SER SER ARG ARG PRO LEU ALA GLU LEU LEU SEQRES 14 B 178 LEU GLU GLU PRO PHE PRO GLN PRO GLU MODRES 3E39 MSE A 90 MET SELENOMETHIONINE MODRES 3E39 MSE A 107 MET SELENOMETHIONINE MODRES 3E39 MSE B 90 MET SELENOMETHIONINE MODRES 3E39 MSE B 107 MET SELENOMETHIONINE HET MSE A 90 8 HET MSE A 107 13 HET MSE B 90 8 HET MSE B 107 8 HET ACT A 178 4 HET ACT A 179 4 HET FMN A 200 31 HET ACT B 178 4 HET FMN B 200 31 HET PGE B 201 10 HETNAM MSE SELENOMETHIONINE HETNAM ACT ACETATE ION HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM PGE TRIETHYLENE GLYCOL HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 1 MSE 4(C5 H11 N O2 SE) FORMUL 3 ACT 3(C2 H3 O2 1-) FORMUL 5 FMN 2(C17 H21 N4 O9 P) FORMUL 8 PGE C6 H14 O4 FORMUL 9 HOH *373(H2 O) HELIX 1 1 ASN A 5 ARG A 14 1 10 HELIX 2 2 SER A 26 TRP A 39 1 14 HELIX 3 3 SER A 42 ASN A 46 5 5 HELIX 4 4 PRO A 59 ALA A 66 1 8 HELIX 5 5 TYR A 70 ALA A 77 1 8 HELIX 6 6 GLU A 88 MSE A 90 5 3 HELIX 7 7 ASN A 92 LEU A 114 1 23 HELIX 8 8 GLY A 122 ASN A 126 5 5 HELIX 9 9 GLN A 127 LEU A 135 1 9 HELIX 10 10 PRO A 163 LEU A 168 1 6 HELIX 11 11 ASN B 5 ARG B 14 1 10 HELIX 12 12 SER B 26 TRP B 39 1 14 HELIX 13 13 ASP B 58 HIS B 67 1 10 HELIX 14 14 TYR B 70 ALA B 77 1 8 HELIX 15 15 GLU B 88 MSE B 90 5 3 HELIX 16 16 ASN B 92 LEU B 114 1 23 HELIX 17 17 GLY B 122 ASN B 126 5 5 HELIX 18 18 GLN B 127 LEU B 135 1 9 HELIX 19 19 PRO B 163 LEU B 168 1 6 SHEET 1 A 4 CYS A 49 ARG A 55 0 SHEET 2 A 4 VAL A 79 ASP A 86 -1 O LEU A 82 N LEU A 52 SHEET 3 A 4 LEU A 142 GLY A 151 -1 O ALA A 146 N VAL A 83 SHEET 4 A 4 GLY A 117 LEU A 121 -1 N GLY A 117 O GLY A 151 SHEET 1 B 4 CYS B 49 ARG B 55 0 SHEET 2 B 4 VAL B 79 ASP B 86 -1 O ILE B 80 N ILE B 54 SHEET 3 B 4 LEU B 142 GLY B 151 -1 O ALA B 146 N VAL B 83 SHEET 4 B 4 GLY B 117 LEU B 121 -1 N LEU B 121 O ALA B 147 LINK C ALA A 89 N MSE A 90 1555 1555 1.33 LINK C MSE A 90 N TYR A 91 1555 1555 1.34 LINK C ASN A 106 N MSE A 107 1555 1555 1.33 LINK C MSE A 107 N LEU A 108 1555 1555 1.34 LINK C ALA B 89 N MSE B 90 1555 1555 1.33 LINK C MSE B 90 N TYR B 91 1555 1555 1.33 LINK C ASN B 106 N MSE B 107 1555 1555 1.33 LINK C MSE B 107 N LEU B 108 1555 1555 1.32 SITE 1 AC1 6 GLU A 123 GLY B 43 TYR B 91 LYS B 95 SITE 2 AC1 6 HOH B 263 HOH B 314 SITE 1 AC2 5 TYR A 91 LYS A 95 GLY B 122 GLU B 123 SITE 2 AC2 5 HOH B 391 SITE 1 AC3 4 GLY A 43 LEU A 44 HOH A 281 HOH A 317 SITE 1 AC4 22 ARG A 14 ARG A 15 SER A 16 ARG A 18 SITE 2 AC4 22 TYR A 70 ILE A 73 TRP A 120 LEU A 121 SITE 3 AC4 22 GLY A 122 GLU A 123 SER A 159 ARG A 161 SITE 4 AC4 22 HOH A 212 HOH A 226 HOH A 248 HOH A 252 SITE 5 AC4 22 PRO B 41 SER B 42 GLY B 43 ASN B 45 SITE 6 AC4 22 LYS B 95 HOH B 298 SITE 1 AC5 21 PRO A 41 SER A 42 GLY A 43 ASN A 45 SITE 2 AC5 21 TYR A 91 LYS A 95 ARG B 14 ARG B 15 SITE 3 AC5 21 SER B 16 ARG B 18 TYR B 70 TRP B 120 SITE 4 AC5 21 LEU B 121 GLY B 122 GLU B 123 SER B 159 SITE 5 AC5 21 ARG B 161 HOH B 207 HOH B 227 HOH B 272 SITE 6 AC5 21 HOH B 367 SITE 1 AC6 7 ARG A 87 PRO A 139 PRO A 174 GLN A 175 SITE 2 AC6 7 SER B 158 HOH B 227 HOH B 280 CRYST1 47.780 67.990 99.740 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020929 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014708 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010026 0.00000 MASTER 340 0 10 19 8 0 19 6 0 0 0 28 END